COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Adamas Pharmaceuticals Inc | COMM | 00548A106 | 754 | 29,192 | SH | | SOLE | | 29,192 | 0 | 0 |
Aduro Biotech Inc | COMM | 00739L101 | 174 | 24,857 | SH | | SOLE | | 24,857 | 0 | 0 |
Aimmune Therapeutics Inc | COMM | 00900T107 | 1,036 | 38,528 | SH | | SOLE | | 38,528 | 0 | 0 |
Alexion Pharmaceuticals Inc | COMM | 015351109 | 1,800 | 14,498 | SH | | SOLE | | 14,498 | 0 | 0 |
Allergan plc | COMM | G0177J108 | 1,916 | 11,490 | SH | | SOLE | | 11,490 | 0 | 0 |
AMAG Pharmaceuticals Inc | COMM | 00163U106 | 287 | 14,695 | SH | | SOLE | 1 | 14,695 | 0 | 0 |
AstraZeneca PLC | ADR | 046353108 | 1,193 | 33,981 | SH | | SOLE | | 33,981 | 0 | 0 |
bluebird bio Inc | COMM | 09609G100 | 896 | 5,707 | SH | | SOLE | | 5,707 | 0 | 0 |
Blueprint Medicines Corp | COMM | 09627Y109 | 603 | 9,499 | SH | | SOLE | | 9,499 | 0 | 0 |
Calithera Biosciences Inc | COMM | 13089P101 | 153 | 30,622 | SH | | SOLE | | 30,622 | 0 | 0 |
Catalyst Pharmaceuticals Inc | COMM | 14888U101 | 503 | 161,089 | SH | | SOLE | | 161,089 | 0 | 0 |
Celgene Corp | COMM | 151020104 | 1,510 | 19,014 | SH | | SOLE | | 19,014 | 0 | 0 |
ChemoCentryx Inc | COMM | 16383L106 | 90 | 6,836 | SH | | SOLE | | 6,836 | 0 | 0 |
Clearside Biomedical Inc | COMM | 185063104 | 477 | 44,620 | SH | | SOLE | | 44,620 | 0 | 0 |
Conatus Pharmaceuticals Inc | COMM | 20600T108 | 380 | 88,742 | SH | | SOLE | | 88,742 | 0 | 0 |
CRISPR Therapeutics AG | COMM | H17182108 | 1,210 | 20,600 | SH | Put | SOLE | | 20,600 | 0 | 0 |
Dermira Inc | COMM | 24983L104 | 345 | 37,543 | SH | | SOLE | | 37,543 | 0 | 0 |
Esperion Therapeutics Inc | COMM | 29664W105 | 610 | 15,571 | SH | | SOLE | | 15,571 | 0 | 0 |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 361 | 72,017 | SH | | SOLE | | 72,017 | 0 | 0 |
Forty Seven Inc | COMM | 34983P104 | 39 | 2,442 | SH | | SOLE | | 2,442 | 0 | 0 |
GW Pharmaceuticals PLC | ADR | 36197T103 | 907 | 6,497 | SH | | SOLE | | 6,497 | 0 | 0 |
Heron Therapeutics Inc | COMM | 427746102 | 1,035 | 26,644 | SH | | SOLE | | 26,644 | 0 | 0 |
Innate Pharma SA | COMM | F5277D100 | 62 | 11,418 | SH | | SOLE | | 11,418 | 0 | 0 |
Intercept Pharmaceuticals Inc | COMM | 45845P108 | 923 | 11,005 | SH | | SOLE | | 11,005 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 552 | 138,249 | SH | | SOLE | | 138,249 | 0 | 0 |
Kadmon Holdings Inc | Warrant | 48283N106 | 38 | 59,909 | SH | | SOLE | | 59,909 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 443 | 32,248 | SH | | SOLE | | 32,248 | 0 | 0 |
Kura Oncology Inc | COMM | 50127T109 | 315 | 17,295 | SH | | SOLE | | 17,295 | 0 | 0 |
OncoMed Pharmaceuticals Inc | COMM | 68234X102 | 159 | 68,899 | SH | | SOLE | | 68,899 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 385 | 99,874 | SH | | SOLE | | 99,874 | 0 | 0 |
PTC Therapeutics Inc | COMM | 69366J200 | 442 | 13,104 | SH | | SOLE | | 13,104 | 0 | 0 |
Puma Biotechnology Inc | COMM | 74587V107 | 378 | 6,384 | SH | | SOLE | | 6,384 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 325 | 9,307 | SH | | SOLE | | 9,307 | 0 | 0 |
Rhythm Pharmaceuticals Inc | COMM | 76243J105 | 452 | 14,452 | SH | | SOLE | | 14,452 | 0 | 0 |
Rigel Pharmaceuticals Inc | COMM | 766559603 | 663 | 234,107 | SH | | SOLE | | 234,107 | 0 | 0 |
Sarepta Therapeutics Inc | COMM | 803607100 | 659 | 4,986 | SH | | SOLE | | 4,986 | 0 | 0 |
Savara Inc | COMM | 805111101 | 299 | 26,441 | SH | | SOLE | | 26,441 | 0 | 0 |
Spectrum Pharmaceuticals Inc | COMM | 84763A108 | 367 | 17,488 | SH | | SOLE | | 17,488 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 87 | 12,354 | SH | | SOLE | | 12,354 | 0 | 0 |
AMAG Pharmaceuticals Inc | COMM | 00163U106 | 814 | 41,727 | SH | | OTR | | 41,727 | 0 | 0 |
Adamas Pharmaceuticals Inc | COMM | 00548A106 | 2,142 | 82,912 | SH | | OTR | 1 | 82,912 | 0 | 0 |
Aduro Biotech Inc | COMM | 00739L101 | 494 | 70,601 | SH | | OTR | 1 | 70,601 | 0 | 0 |
Aimmune Therapeutics Inc | COMM | 00900T107 | 2,944 | 109,496 | SH | | OTR | 1 | 109,496 | 0 | 0 |
Alexion Pharmaceuticals Inc | COMM | 015351109 | 5,112 | 41,179 | SH | | OTR | 1 | 41,179 | 0 | 0 |
Allergan plc | COMM | G0177J108 | 5,441 | 32,635 | SH | | OTR | 1 | 32,635 | 0 | 0 |
AstraZeneca PLC | ADR | 046353108 | 3,387 | 96,478 | SH | | OTR | 1 | 96,478 | 0 | 0 |
Blueprint Medicines Corp | COMM | 09627Y109 | 1,713 | 26,979 | SH | | OTR | 1 | 26,979 | 0 | 0 |
CRISPR Therapeutics AG | COMM | H17182108 | 3,437 | 58,500 | SH | Put | OTR | 1 | 58,500 | 0 | 0 |
Calithera Biosciences Inc | COMM | 13089P101 | 435 | 86,939 | SH | | OTR | 1 | 86,939 | 0 | 0 |
Catalyst Pharmaceuticals Inc | COMM | 14888U101 | 1,523 | 488,243 | SH | | OTR | 1 | 488,243 | 0 | 0 |
Celgene Corp | COMM | 151020104 | 4,288 | 53,991 | SH | | OTR | 1 | 53,991 | 0 | 0 |
ChemoCentryx Inc | COMM | 16383L106 | 257 | 19,514 | SH | | OTR | 1 | 19,514 | 0 | 0 |
Clearside Biomedical Inc | COMM | 185063104 | 1,354 | 126,652 | SH | | OTR | 1 | 126,652 | 0 | 0 |
Conatus Pharmaceuticals Inc | COMM | 20600T108 | 1,082 | 252,723 | SH | | OTR | 1 | 252,723 | 0 | 0 |
Dermira Inc | COMM | 24983L104 | 981 | 106,593 | SH | | OTR | 1 | 106,593 | 0 | 0 |
Esperion Therapeutics Inc | COMM | 29664W105 | 1,733 | 44,224 | SH | | OTR | 1 | 44,224 | 0 | 0 |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 1,091 | 217,670 | SH | | OTR | 1 | 217,670 | 0 | 0 |
Forty Seven Inc | COMM | 34983P104 | 111 | 6,935 | SH | | OTR | 1 | 6,935 | 0 | 0 |
GW Pharmaceuticals PLC | ADR | 36197T103 | 2,575 | 18,452 | SH | | OTR | 1 | 18,452 | 0 | 0 |
Heron Therapeutics Inc | COMM | 427746102 | 2,939 | 75,645 | SH | | OTR | 1 | 75,645 | 0 | 0 |
Innate Pharma SA | COMM | F5277D100 | 177 | 32,422 | SH | | OTR | 1 | 32,422 | 0 | 0 |
Intercept Pharmaceuticals Inc | COMM | 45845P108 | 2,622 | 31,248 | SH | | OTR | 1 | 31,248 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 1,570 | 393,476 | SH | | OTR | 1 | 393,476 | 0 | 0 |
Kadmon Holdings Inc | Warrant | 48283N106 | 154 | 240,091 | SH | | OTR | 1 | 240,091 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 1,259 | 91,662 | SH | | OTR | 1 | 91,662 | 0 | 0 |
Kura Oncology Inc | COMM | 50127T109 | 894 | 49,121 | SH | | OTR | 1 | 49,121 | 0 | 0 |
OncoMed Pharmaceuticals Inc | COMM | 68234X102 | 483 | 209,088 | SH | | OTR | 1 | 209,088 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 1,146 | 297,559 | SH | | OTR | 1 | 297,559 | 0 | 0 |
PTC Therapeutics Inc | COMM | 69366J200 | 1,255 | 37,203 | SH | | OTR | 1 | 37,203 | 0 | 0 |
Puma Biotechnology Inc | COMM | 74587V107 | 1,073 | 18,132 | SH | | OTR | 1 | 18,132 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 925 | 26,439 | SH | | OTR | 1 | 26,439 | 0 | 0 |
Rhythm Pharmaceuticals Inc | COMM | 76243J105 | 1,283 | 41,047 | SH | | OTR | 1 | 41,047 | 0 | 0 |
Rigel Pharmaceuticals Inc | COMM | 766559603 | 1,882 | 664,917 | SH | | OTR | 1 | 664,917 | 0 | 0 |
Sarepta Therapeutics Inc | COMM | 803607100 | 1,872 | 14,160 | SH | | OTR | 1 | 14,160 | 0 | 0 |
Savara Inc | COMM | 805111101 | 850 | 75,099 | SH | | OTR | 1 | 75,099 | 0 | 0 |
Spectrum Pharmaceuticals Inc | COMM | 84763A108 | 1,043 | 49,743 | SH | | OTR | 1 | 49,743 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 246 | 35,027 | SH | | OTR | 1 | 35,027 | 0 | 0 |
bluebird bio Inc | COMM | 09609G100 | 2,544 | 16,209 | SH | | OTR | 1 | 16,209 | 0 | 0 |
AMAG Pharmaceuticals Inc | COMM | 00163U106 | 1,679 | 86,089 | SH | | OTR | 2 | 86,089 | 0 | 0 |
Adamas Pharmaceuticals Inc | COMM | 00548A106 | 4,425 | 171,294 | SH | | OTR | 2 | 171,294 | 0 | 0 |
Aduro Biotech Inc | COMM | 00739L101 | 1,021 | 145,860 | SH | | OTR | 2 | 145,860 | 0 | 0 |
Aimmune Therapeutics Inc | COMM | 00900T107 | 6,105 | 227,020 | SH | | OTR | 2 | 227,020 | 0 | 0 |
Alexion Pharmaceuticals Inc | COMM | 015351109 | 10,562 | 85,075 | SH | | OTR | 2 | 85,075 | 0 | 0 |
Allergan plc | COMM | G0177J108 | 11,241 | 67,425 | SH | | OTR | 2 | 67,425 | 0 | 0 |
AstraZeneca PLC | ADR | 046353108 | 6,999 | 199,341 | SH | | OTR | 2 | 199,341 | 0 | 0 |
Blueprint Medicines Corp | COMM | 09627Y109 | 3,537 | 55,722 | SH | | OTR | 2 | 55,722 | 0 | 0 |
CRISPR Therapeutics AG | COMM | H17182108 | 7,104 | 120,900 | SH | Put | OTR | 2 | 120,900 | 0 | 0 |
Calithera Biosciences Inc | COMM | 13089P101 | 898 | 179,662 | SH | | OTR | 2 | 179,662 | 0 | 0 |
Catalyst Pharmaceuticals Inc | COMM | 14888U101 | 2,498 | 800,625 | SH | | OTR | 2 | 800,625 | 0 | 0 |
Celgene Corp | COMM | 151020104 | 8,847 | 111,394 | SH | | OTR | 2 | 111,394 | 0 | 0 |
ChemoCentryx Inc | COMM | 16383L106 | 552 | 41,908 | SH | | OTR | 2 | 41,908 | 0 | 0 |
Clearside Biomedical Inc | COMM | 185063104 | 2,797 | 261,632 | SH | | OTR | 2 | 261,632 | 0 | 0 |
Conatus Pharmaceuticals Inc | COMM | 20600T108 | 2,214 | 517,385 | SH | | OTR | 2 | 517,385 | 0 | 0 |
Dermira Inc | COMM | 24983L104 | 2,026 | 220,204 | SH | | OTR | 2 | 220,204 | 0 | 0 |
Esperion Therapeutics Inc | COMM | 29664W105 | 3,581 | 91,366 | SH | | OTR | 2 | 91,366 | 0 | 0 |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 1,967 | 392,712 | SH | | OTR | 2 | 392,712 | 0 | 0 |
Forty Seven Inc | COMM | 34983P104 | 229 | 14,323 | SH | | OTR | 2 | 14,323 | 0 | 0 |
GW Pharmaceuticals PLC | ADR | 36197T103 | 5,319 | 38,121 | SH | | OTR | 2 | 38,121 | 0 | 0 |
Heron Therapeutics Inc | COMM | 427746102 | 6,072 | 156,296 | SH | | OTR | 2 | 156,296 | 0 | 0 |
Innate Pharma SA | COMM | F5277D100 | 365 | 66,948 | SH | | OTR | 2 | 66,948 | 0 | 0 |
Intercept Pharmaceuticals Inc | COMM | 45845P108 | 5,418 | 64,564 | SH | | OTR | 2 | 64,564 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 3,742 | 937,858 | SH | | OTR | 2 | 937,858 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 2,464 | 179,466 | SH | | OTR | 2 | 179,466 | 0 | 0 |
Kura Oncology Inc | COMM | 50127T109 | 1,847 | 101,484 | SH | | OTR | 2 | 101,484 | 0 | 0 |
OncoMed Pharmaceuticals Inc | COMM | 68234X102 | 273 | 118,257 | SH | | OTR | 2 | 118,257 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 2,243 | 582,545 | SH | | OTR | 2 | 582,545 | 0 | 0 |
PTC Therapeutics Inc | COMM | 69366J200 | 2,590 | 76,772 | SH | | OTR | 2 | 76,772 | 0 | 0 |
Puma Biotechnology Inc | COMM | 74587V107 | 2,213 | 37,420 | SH | | OTR | 2 | 37,420 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 1,894 | 54,163 | SH | | OTR | 2 | 54,163 | 0 | 0 |
Rhythm Pharmaceuticals Inc | COMM | 76243J105 | 2,651 | 84,801 | SH | | OTR | 2 | 84,801 | 0 | 0 |
Rigel Pharmaceuticals Inc | COMM | 766559603 | 3,888 | 1,373,703 | SH | | OTR | 2 | 1,373,703 | 0 | 0 |
Sarepta Therapeutics Inc | COMM | 803607100 | 3,867 | 29,254 | SH | | OTR | 2 | 29,254 | 0 | 0 |
Savara Inc | COMM | 805111101 | 1,756 | 155,152 | SH | | OTR | 2 | 155,152 | 0 | 0 |
Spectrum Pharmaceuticals Inc | COMM | 84763A108 | 2,153 | 102,734 | SH | | OTR | 2 | 102,734 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 360 | 51,232 | SH | | OTR | 2 | 51,232 | 0 | 0 |
bluebird bio Inc | COMM | 09609G100 | 5,251 | 33,455 | SH | | OTR | 2 | 33,455 | 0 | 0 |
Aclaris Therapeutics | Common Shares | 00461U105 | 30,743 | 1,539,480 | SH | | SOLE | | 1,539,480 | 0 | 0 |
Amarin | American Depositary Shares | 023111206 | 10,264 | 3,321,587 | SH | | SOLE | | 3,321,587 | 0 | 0 |
Amarin | Ordinary Shares | 023111206 | 0 | 1 | SH | | SOLE | | 1 | 0 | 0 |
Amarin | Series A Preferred Stock | 023111PR2 | 12,010 | 3,886,718 | SH | | SOLE | | 3,886,718 | 0 | 0 |
Apellis Pharmaceuticals, Inc | Common Shares | 03753U106 | 13,548 | 615,802 | SH | | SOLE | | 615,802 | 0 | 0 |
Ascendis Pharma A/S | American Depositary Shares | 04351P101 | 66,423 | 998,538 | SH | | SOLE | | 998,538 | 0 | 0 |
Ascendis Pharma A/S | Ordinary Shares | 04351P101 | 98,515 | 1,480,976 | SH | | SOLE | | 1,480,976 | 0 | 0 |
Audentes Therapeutics | Common Shares | 05070R104 | 35,674 | 933,640 | SH | | SOLE | | 933,640 | 0 | 0 |
Auris Medical Holding AG (frmlyAuris Medical) | Warrant(s) | H0381L104 | 0 | 140,000 | SH | | SOLE | | 140,000 | 0 | 0 |
Chiasma | Common Shares | 16706W102 | 2,445 | 1,630,221 | SH | | SOLE | | 1,630,221 | 0 | 0 |
Chiasma | Warrant(s) | 16706W102 | 0 | 136,881 | SH | | SOLE | | 136,881 | 0 | 0 |
Coherus BioSciences (frmly Intekrin) | Common Shares | 19249H103 | 40,505 | 2,893,221 | SH | | SOLE | | 2,893,221 | 0 | 0 |
Edge Therapeutics | Common Shares | 279870109 | 2,938 | 2,852,711 | SH | | SOLE | | 2,852,711 | 0 | 0 |
Histogenics | Common Shares | 43358V109 | 5,193 | 2,077,040 | SH | | SOLE | | 2,077,040 | 0 | 0 |
Iterum Therapeutics | Common Shares | G6333L101 | 18,802 | 1,726,514 | SH | | SOLE | | 1,726,514 | 0 | 0 |
Kiniksa Pharmaceuticals, Ltd | Common Stock Class A | G5269C101 | 16,009 | 922,700 | SH | | SOLE | | 922,700 | 0 | 0 |
Merus N.V. | Common Shares | N5749R100 | 44,633 | 1,961,039 | SH | | SOLE | | 1,961,039 | 0 | 0 |
Natera | Common Shares | 632307104 | 58,353 | 3,100,560 | SH | | SOLE | | 3,100,560 | 0 | 0 |
Nucana Biomed | American Depositary Shares | 67022C106 | 12,667 | 666,666 | SH | | SOLE | | 666,666 | 0 | 0 |
Nucana Biomed | Ordinary Shares | GB00BYWYV | 76,000 | 4,000,000 | SH | | SOLE | | 4,000,000 | 0 | 0 |
ObsEva SA | Common Shares | H5861P103 | 71,909 | 4,749,623 | SH | | SOLE | | 4,749,623 | 0 | 0 |
Spark Therapeutics | Common Shares | 84652J103 | 39,830 | 481,270 | SH | | SOLE | | 481,270 | 0 | 0 |
Synlogic Inc. (fmrly Mirna) | Common Shares | 87166L100 | 5,652 | 574,972 | SH | | SOLE | | 574,972 | 0 | 0 |